Clinical Trial Update: Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age [Phase 2]

View source ↗

Summary

Phase 2 pediatric study evaluating the pharmacokinetics, safety, and tolerability of tigecycline in children aged 8 to 11 years has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Bacterial Pneumonia
• Bacterial Skin Infection
• Infectious Skin Diseases
• Intra-abdominal Infection

Drugs mentioned

• Tigecycline (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Bacterial Infections, Intra-Abdominal Infection | Phase 2 | Status: COMPLETED | Results posted: 2012-10-24